<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 326 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page325.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=326">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 326 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 326</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=326"><img src="../thumb/326.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Endocrine System - 19.1.2                                                      2020-04 / 289
       Drug interactions: Poss.bld.gluc. chang.with CYP 2C9 induc./ in-  Special precautions: Ren/hepat.impairm., elderly, debili-  (S3) TABS, 39/21.2/0638, 0639, 41/21.2/0193
       hib., potent.of effs.poss.with insul. & other oral antidiab./ MAOI/   tat., malnourish., adren./pituit. insuffic., assoc.incr.CV mortal.  708281-001: 500 mg, 100, R42,00
       ACE inhibit./ miconazole/ anabol.ster.& male sex horm./para-amino-  as compar.to diet alone/diet & insulin., monit.bld.gluc.caref.  708282-001: 850 mg, 60, R44,40
       salicyl.acid/ chloramphenicol/pentoxifylline/ coumarin derivat./ phe-  in ren. impairm.  709172-001: 1 000 mg, 60, R51,65
       nylbutazone/azapropazone/ oxyphenbutazone/ cyclophosphamide/   Drug interactions: Sulphonamid./salicylates/ phenylbutazone/ß-  Dosage: Admin.in div.dos. with meals.
       disopyramide, quinolones/salicylates/ sulphinpyrazone/ fibrates/  adrenocept.block.agents/ MAOI/ ketoconazole/miconazole/ chlo-  Adults: Init. 500 mg 3x/day. Aft.10-15 days adjust dos. or incr.to
       sulfonamide antibiot./ fluoxetine/ tetracycl./guanethidine/ifosfa-  ramphen./ clofibrate/halofenate/ cyclophosphamide/ dicoumarol   850-1000 mg 2x/day. If contr. incompl. caut.incr.to max.of 3 g/day.
       mide/ fluconazole/ clarithromycin, weaken.eff.with acetazolamide/   & cimetid.may potent hypoglycaem. act., thiaz.diuret./corticos-  Poss.reduc. dos.once contr.
       laxativ./barbit./nicotin.acid/ corticoster./ oestrogens & progestog./  ter./oestrog.& adrenal. may dimin.act., ß-blocks.may mask hypo-  Contraindications: Diabet.ketoacidos., diabet. pre-coma/hist.
       diazoxide/ phenothiazin./ diuret./phenytoin/epinephrine & other   glycaem. sympt.  thereof, imp.ren.funct., pancreatit., chron.liv.dis., hist.of/states assoc.
       sympathomimet./rifampicin/glucagon/ thyroid hormon., H 2-recept.  AUSTELL-GLIMEPIRIDE, Austell [P/S]  with lact.acidos., card.fail./rec.MI, condits.assoc.with hypox., hepat.
       antagon./beta-blocks/ clonidine/ reserpine poss.potent./dimin.eff.,   insuffic., ac.alcohol intoxicat., alcohol., safety in pregn.& lactat.not
       signs of adrenerg.counter-regulat.to hypoglycaem. may be reduc./   Glimepiride.  est., safety & effic.in childr.not est., pregn., safety in lactat.not est.
       absent under the influence of sympatholyt., alcoh.may potent./weak.  Indications: Type 2 diab.mellit.not control.by diet. & exerc.alone.  Side effects: Lact.acidos., megablast.anaem., metal.taste, GI dis-
                                     (S3) TABS. A40/21.2/0193, 0194, 0196
       eff., coumar. deriv.eff.potent./weak.                      turbs., ketoacidos., ketonur., sev.cholestat.hepatit., hypersens., hy-
                                     717076-001: 1 mg, 30, R65,97  poglycaem., mal-absorpt.of Vit.B12 from GIT.
       AMARYL COMBI, Sanofi-Aventis [P/S]  717077-001: 2 mg, 30, R129,34  Special precautions: Discont.& hospitalis. immed. if metabol.
       Glimepiride 2 mg, metformin HCl 500 mg  717078-001: 4 mg, 30, R200,94  acidos.suspect., monit.ren. funct. reg.esp. elderly, condits.where
       Indications: Adjunct.to diet & exerc.in non insul. depend.diab.mel-  Dosage: Indiv.accord.to bld.gluc.lev.at low.dos.to achiev.desir.  ren.funct. may become imp., incr.cardiovasc.mortal.compar. to diet
       lit.who are well-contr.& stabilis. on indiv.compon.in same ratio where   metabol.contr. Swall. whole bef.a substant. breakf./1st main.meal
       monother. with glimepiride or metformin did not result.in adeq.gly-  of the day. Take at same time dly. Meals not to be miss.aft.tabs.   alone/diet + insul.ther., discont.ther.bef. intravasc.admin.of iodinat.
                                                                  contrast agents allow. 48 hr.interv.bef.re-comm.ther., discont.48 hrs.
       caem.contr.or replacem.of glimepiride & metformin.combin.ther.  admin. Sngl.dly.dos.norm.suffic.to provide metabol. contr.over 24   bef. elect.surg., poss.hypoglycaem.with concom.insulin / sulfonylure-
       (S3) TABS. 43/21.2/0005       hrs. Init: 1 mg once dly. which may be incr.grad.at 1-2 wk.interv.  as, annual monit.of Vit B12, condits. caus.dehydrat., infect./trauma/
       718106-001: 30, R201,18       by 1 mg-2 mg-3 mg-4 mg-6 mg increm. Max.dos.8 mg/day. Usual.  low calor.diet, stabilisat.of pts.on combin.ther.in hosp.
       Dosage: Indiv. Init.low. eff.dos. Dos.incr.depend. on bld. gluc.lev.   dly.dos: 1-4 mg. Improv.diab.contr.is assoc. with improv.insul.sensi-
       Admin.1 tab once or 2x dly bef. or with meals. When switch.from   tiv.allow.for reduc. requirem. theref.dos.reduct.must be consid.in   Warnings: Reduc.incid.of lactat.acidos.by assess. assoc.risk fact.
                                                                  eg.poor.controll.diab./ketosis, prolong. fast./excess.alcoh.intake/
       combin.ther.of glimepiride plus metformin as separ.tabs., admin.   time. When switch.from other oral antidiab.init.treatm. as above.  hepat.insuffic.& other condits.assoc.with hypox., concom. gluco-
       Amaryl Combi on basis of dos. current. taken.  Contra-indications: Sulphonylurea or other sulphonamide hyper-  cortic. / ß2-agonists & diuret.due to intrinsic hyperglycaem.effs.
       Contraindications: Sulphonylur./other sulphonam. hypersens.,   sens., safety in pregn. & lactat.not est., imp.liv. funct., mod.to sev.  Drug interactions: ACE-inhibit.poss.decr.bld. gluc. lev., reduc.
       insul.-depend.(type 1) diab.mellit., diab.ketonaem., diab.coma/pre-  imp. ren.funct., childr., type 1 diab.mellit.
       coma, ac./chron.metabol.acidos., ren.dysfunct., pancreatit., safety   Side-effects: Bld.dyscras., CNS effs.incl. headache, dizzin., hypo-  clear.with cimetidine, activ.of warfar. dimin., poss.hypoglycaem.
                                                                  with concom. sulphonylurea.
       in pregn.& lactat.not est., hist. of/states assoc.with lact.acidos.  glycaem.somet.life-threat., GI disturbs., taste alt., polyur., choles-
       incl.shock, CF, rec. MI, condits.assoc.with hypox., hepat.insuffic.,   tas., cholestat. jaund., hepatit., liv.funct.impairm.poss. progress.  BIO GLIBENCLAMIDE, Biotech [P/S]
       ac. alcoh.intox., alcohol., IV iodinat.contrast mater., sev. infect.bef./  to liv.fail., blurr.vis./accommodat.chang. esp.at start of treatm.,   Glibenclamide.
       aft.surg.& ser.trauma, malnourish./ fast./debilit.pts., pituit./adren.  skin reacts.incl.erythem. multiform., allerg.vasculit., photosens.,   Indications: Adjunct.to diet to lower bld.gluc. lev. in pts.with
       insuffic., porphyr., safety & effic.in childr.not est.  anaphylact. respons.  NIDDM.
       Side-effects: Hypoglycaem., tempor.vis.impairm. esp.at start of   Special precautions: Incr.CV mortalit. report. with sulphonylur.  (S3) TABS. V/21.2/0345
       treatm., GI disturbs., liv.funct. impairm., hepatit.poss.lead.to liv.fail.,   anti-diab. agent: tolbutamide esp.in high risk myocard.ischaem.pts.,   827053-002: 5 mg, 500, R158,24
       bld.dyscras., allerg./pseudoallerg.reacts.somet.progress.to shock, al-  bld.& urine gluc.lev. meas. regul.dur.ther., regul.determin.of proport.  Dosage: Indiv.&determine by examinat.results. Take with /im-
       lerg.vasculit., light hypersens.of skin, metall.taste, headache, weight   of glycosylat. Hb, fact.predispos.to hypoglycaem., pt.instruct.on signs   med.aft. meal.
       loss, lact.acidos., decr.Vit B 12 /folic acid absorpt., hypersens., Vit.B 12   of hypoglycaem., hypo-/hyperglycaem.poss.impair alertn.& reacts.  Init.2,5 mg/day. Incr.dly.dose grad.in 2,5 mg steps aft.repeat.medic.
       malabsorpt.poss.result.in megaloblast.anaem.  esp.when init./alt.dos., hypoglycaem. risk incr.in init.ther.theref.   exam. Dos.over 15 mg/ day do not produc.incr.respons.
       Special precautions: Incr.CV mortal.risk as comp. to treatm.with   monit. essent., hypoglycaem.sympts.mediat.by counter-regulat.   Contraindications: Diabet.complicat.by fev./ trauma or gangr., imp.
       diet alone/diet with insul., pt. inform.of potent.risk/benef.of sulph-  hormon.respons., convert pt.tempor.to insul. to maint.good metab.  ren./hepat.funct., ser. thyroid/ adren.funct.impairm., metab. decom-
       onylur./alt. ther., ser.creatin.lev.bef.init.ther.& reg.aft., ren. funct.  contr.dur.except. stressors.  pensat. hist., diabet.mellit.in young people, pregn.
       impairm., elderly, discont.ther.2-3 days bef. elect.surg.with gen.  Drug interactions: Hypoglycaem.poss.with allopurin./ anabol.  Side effects: N&V, epigastr.pain, dizzin., headache, paraesth.,
       anaesthes./IV urography & IV angiography & reinst.aft.ren.funct.  ster.& androgens/ACE inhibit./ disopyramide/ chloramphenicol/  weakn., sensitiv.reacts., alcoh.intol., hypoglycaem.reacts,
       contr.regain., adeq.bld./urine gluc.lev.monit.reg., discont.ther. im-  sulphonamide antibiot. /quinolon./tetracycl./coumar.derivat. /   Special precautions: Report pregn.immed., dos. adjust.in re-
       med.if metabol.acidos.susp., reduc.incid.of lact.acidos.by assess.  fluoxet./ cyclophospham./ifosfamide/ trofosfamide/ fenfluramine/  curr.infect./trauma/shock or aft. anaesth., implem.insul.ther.if maj.
       assoc.risk fact., lact.acidos. poss.occur with concom.iodinat con-  azole antifung./ß-block./ fenyramidol/clofibrate/guanethidine/ insul.   surg.to be perform.
       trast mater. /antibiot.having strong nephrotoxic., pregn./plann.   & other oral antidiab./MAOI/para-aminosalicyl. acid/ pentoxifylline   Drug interactions: Hypoglycaem.eff.enhanc.by chloramphenicol/
       pregn.recomm.to switch to insul., correct diet/reg. & suffic.exerc./  (high parent.dos)/ phenylbutazone/ azapropazone/oxyphenbuta-  clofibrate/halofenate/cyclophosphamide/ dicoumarol/MAOI/salicy-
       bm reduct.necess., caref.monit.esp. dur.init.wks.of ther.& poss.dos.  zone/ probenecid/ sulphinpyrazone & tritoqualine, hyperglycaem.   lates/ phenylbutazone/ propanolol/other ß-adrenerg. block. agents
       adjustm., sev./ persist.hypoglycaem., gluc.contr.poss.deterior.dur.   poss.with acetazolamide/adrenal.& other sympathomimet./bar-  & sulphonamides, hypoglycaem.eff. dimin.by adrenal./oestrog./
       extrem.stress eg.trauma/surg./ac.febr.illn., annual Vit.B 12 monit.dur.  bitur./corticoster./ diazoxide/ diuret./glucagon/isoniazid/protract.   corticoster.or diuret., propranol poss.masks hypoglycaem.sympts.&
       longt.ther., in-hosp.stabilis.of pts. on Amaryl Combi & insul., incr.hy-  laxativ. use/high dos.nicotin.acid/oestrog.& progestog./ phenothia-  inhibit.norm.physiologic.respons.
       poglycaem.risk dur. init.ther., sev.liv.funct.impairm., predispos. fact.  zin./phenytoin/rifampicin & thyroid hormon., eff.of coumarin deriv.  Warnings: Incr.cardiovasc.mortal.
       to hypoglycaem.developm.      potent./ weaken., alcoh./ß-block./clonidine/reserpine & H 2 recept.
       Drug interactions: Glimepiride metabol.influenc. by concom.  block.may potent./weak.hypoglycaem.eff., sympatholyt. meds.blunt   CIPLA PIOGLITAZONE, Cipla Medpro [P/S]
       CYP2C9 induc./inhibit.[potent.eff.with insul./oral hypoglycaem./   signs of adrenerg. respons. to hypoglycaem.  Pioglitazone
       sulphonamide./ sulphonylur. prod./guanethid./salicylat./beta-  AUSTELL-METFORMIN, Austell [P/S]  Indications: Adjunct to diet in Type 2 diab. either as monother./in
       blocks./ ACE-inhib./allupurinol/anabol.ster./male sex horm./chlo-  Metformin HCl.  combinat.with metformin, a sulphonylurea or insulin when diet &/
       ramphenicol/ coumar.anticoags/ cyclophosphamide/disopyramide/   Indications: Type II diab.mellit.when diet.fail. esp. if pt.overweight.   exerc.& sngl.agent result inadeq.glycaem.control.
       fenfluramine/ fibrat./ fluoxetine/guanethidine/ ifosfamide/MAOI /   admin.alone or as combinat. ther.with a sulphonylurea or insul.  (S3) TABS, A40/21.2/0149, 0150.
       miconazole/fluconazole/para-amonisalicycl.acid/ pentoxifyll./ phe-  (S3) TABS, A38/21.2/0504, 0505  707974-001: 15 mg: 30, R106,80
       nylbutazone/probenecid/ quinolon./ salicylat./sulphinpyrazone/  705757-001: 500 mg, 100, R42,00  707981-001: 30 mg: 30, R179,40
       sulfonamid./ tetracycl./ tritoqualine/trofosfamide/ azapropazone/   705757-002: 500 mg, 500, R209,99  Dosage: Indiv. Take once dly.without regard to meals.
       oxyphenbutazone AND weaken.eff: epinephrine/ corticoster./diu-  705758-001: 850 mg, 60, R44,40  Monother: Init.15-30 mg once dly.incr.if necess. in increm.to
       rets./ pyrazinamide/ isoniazid/ phenothiaz./acetazolamide/barbits/   705758-002: 850 mg, 300, R222,01  max.45 mg once dly.
       diazoxide/ diurets./adrenal.or sympathomimet. agents/ glucagons/  Dosage: Admin.in div.dos.with meals.  Combinat.ther: Init.15-30 mg once dly.in combinat. with curr.dos.
       laxative./nicotin.acid/ oestrog./ progestog./phenytoin/rifampicin/  Adults: Init.500 mg 3x/day. Incr.aft.10-15 days to 850 mg 2x/day.   of other med. If hypoglycaem. report.decr.sulphonylurea dos, or in
       thyroid hormon.], H 2-recept.antagon./clonidine/reserpine/alcoh.&   Caut.incr.to max.3 g/day if contr. incompl.  the case of insulin combinat.ther.either the insulin/pioglitazone dos.
       coumar.deriv. potent.or weaken eff., reduc.gluc. tol./ incr.hypogly-  Contraindications: Ketoacidos., diabet.pre-coma/ hist.thereof,   Contraindications: Hepat.impairm/act.liv.dis., serum transami-
       caem.risk with ß-block., sympatholytic agents reduc./block.signs of   imp.ren.funct., pancreatit., chron.liv.dis., hist.of/states assoc.with   nase levels &gt;2,5x upper norm. limit., CF, pregn., lactat., type 1 diab.
       adrenerg. counter-regulat.to hypoglycaem., concom. nifedipine incr.  lact. acidos. eg.shock/pulmon.insuffic., card.fail., recent MI, con-  mellit., diabet. ketoacidos., safety & effic.in childr.not est., New York
       metform.C max & AUC, cation. drugs.eliminat.by ren.tubul.secret.have   dits.assoc.with hypox., hepat. insuffic., ac.alcoh.intoxicat., alco-  Heart Assoc.class III & IV.
       potent.interact .by compet.for comm.ren. tubul. transp.syst., thiazide/  hol., pregn., safety in lactat.not est., safety & effic.not est.in childr.,   Side effects: Anaem., weight gain, headache, hypoaesthes., in-
       other diurets./corticoster./ phenothiazin./ thyroid prod./oestrog./   Side effects: Lact.acidos., megablast.anaem., metal.taste, GI   somn., vis.disturbs., oed., HF, URTI, revers.elev.liv.enzymes, hepa-
       OC’s/ phenytoin/ nicotin.acid/sympathomimets./Ca block. agents/  disturbs., ketoacidos., ketonur., sev.cholestat.hepatit., hypersens.,   tocellul. dysfunct., myalg., tooth disord., With metformin also:
       isoniazid poss.prod.hyperglycaem.  hypoglycaem.            flatulence, arthralg., haematuria, erect. dysfunct. Also hypogly-
       AUSTELL-GLICLAZIDE, Austell [P/S]  Special precautions: Assess risk fact.assoc. with lact.acidos.,   caem./sweat.& vertigo dur. combinat.ther.with sulphonylurea.
                                                                  Also dyspn. with insulin.
                                     determ.ser.creatin.lev.bef.init. ther.& reg.thereaft., condits.poss.
       Gliclazide.                   impair.ren. funct., ther.assoc.with incr.CV mort., discont.bef. elect.  Special precautions: Liv.funct.monit.essent. bef.init.ther.then 2
       Indications: Maturity onset diabet.mellit.where diet.managem.  surg./clinic.investigat.involv.iodinat. contrast med.admin.& do   mnthly for 1 yr.theraft. periodic., poss.resumpt.of ovulat.in pre-men-
       alone insuffic.               not resume earlier than 48 hrs. aft.& ren.funct.eval., concom.  opaus. anovulat.insul.resist.pts., eff.only exerc.in pres.of insul., Hb
       (S3) TABS, 38/21.2/0206, 0207  insul.or sulphonylurea ther., discont.bef., stabilis.pts.in hosp. if   & haematocrit decr., oed., NYHA class II incr.dos.grad.only aft.sev.
       705759-001: 40 mg, 30, R19,39  concom.insulin admin., not advis.in dehydrat./ ser.infect./trauma   mnths.ther.with careful monit., est.cause of mild.elev.liv.enzyme &
       705760-001: 80 mg, 60, R68,10  or low cal.intake           cont.ther.with extreme caut.discont.if jaund.pres.
       Dosage: Usual.init.dos.40-80 mg dly.incr.grad.if necess.upto 320 mg   Drug interactions: Intrins.hyperglycaem.activ.of glucocortic./beta-  Drug Interactions: Incr.hypoglycaem.risk with concom.oral hypo-
       dly. Admin.dos.more than 160 mg dly.in 2 div.dos.  2-agon.& diuret., ACE inhibit. decr. bld.gluc., reduc. ren. clear.with   glycaem.agents/insulin, poss. reduc.effic.of OC’s, ketoconazole decr.
       Contra-indications: Type I diab.mellit., ketoacidos., sev.infect.,   cimetidine, warfar. activ.dimin., Vit.B absorpt.impair.  metabol., midazolam ser.conc.reduc.
       trauma, condits.where hyperglycaem.contr.unlikely, safety in
       pregn.& lactat.not est.       BIGSENS, Zydus [P/S]         DIAGLUCIDE, Biogaran [P/S]
       Side-effects: GI disturbs., metall.taste, hypersens. reacts.incl.pho-  Metformin HCl.  Gliclazide.
       tosens./cholestat.jaund./ bld.dyscras./erythema multiforme./Stev.-  Indications: Type II diab. when diet fail.& pt.is overweight. May   Indications: Maturity onset diabet.mellit.where diet.managem.
       Johnson syndr./exfoliat.dermat.& erythema nodosum.  be used as monother/combin. with other oral anti-diabet.agents.  alone insuffic.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page325.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>&nbsp;&nbsp;&nbsp;<a href="page329.html">329</a>&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>&nbsp;&nbsp;&nbsp;<a href="page331.html">331</a>
             </td>
             <td width="35%"><a href="page327.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page327.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
